We are live on
!
Find out more
GA
Greenhaven Associates Portfolio holdings
AUM
$8.66B
1-Year Est. Return
17.37%
This Fund
S&P 500
1 Year Est. Return
+17.37%
AUM
$8.66B
AUM Growth
+$2.59B
(+43%)
Holding
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 | +$850M | |
| 2 | +$588M | |
| 3 | +$140M | |
| 4 |
IQVIA
IQV
|
+$134M |
| 5 |
EPAM Systems
EPAM
|
+$62.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 | +$46.2M | |
| 2 | +$40.4M | |
| 3 | +$32.3M | |
| 4 |
Arrow Electronics
ARW
|
+$26.3M |
| 5 |
TMHC
Taylor Morrison
TMHC
|
+$15.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 41.65% |
| 2 | Healthcare | 24.21% |
| 3 | Technology | 13.62% |
| 4 | Industrials | 5.19% |
| 5 | Energy | 3.24% |
Similar funds
MC
NB
IC
PCM
MU
GRQ
DM
FT
Greenhaven Associates's Q2 2026 Portfolio in Review
As of Q2 2026, Greenhaven Associates held 31 positions worth $8.66B, up 43% from $6.07B the previous quarter. Its ten largest holdings account for 79% of the portfolio.
Greenhaven Associates deployed $1.74B of net new capital in Q2 2026, opening 4 new positions and adding to 7 existing holdings. Its largest new stake was Becton Dickinson: 5,681,708 shares worth $860M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 42% of assets, down from 52% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was SLB Ltd, an estimated $46.2M trimmed.
- Greenhaven Associates's largest Q2 2026 buy was Becton Dickinson: 5,681,708 shares worth $860M.
- Greenhaven Associates added most to Icon in Q2 2026, an estimated $140M increase.
- Greenhaven Associates's biggest Q2 2026 reduction was SLB Ltd, cutting an estimated $46.2M.
- Greenhaven Associates fully exited Taylor Morrison in Q2 2026, selling an estimated $15.8M.
- Greenhaven Associates's ten largest holdings make up 79% of its $8.66B portfolio in Q2 2026.
- Greenhaven Associates opened 4 new positions and closed 3 in Q2 2026.
- Greenhaven Associates's portfolio value rose 43% quarter-over-quarter to $8.66B.
Based on Greenhaven Associates's 13F filing for Q2 2026, filed 28 Jul 2026.